MIRD-226: The Intersection of Internal Dosimetry and Radium Recycling for Advanced Cancer Therapy
The MIRD-226 works by emitting beta and gamma radiation, which allows it to interact with living tissue. When administered to a patient, the MIRD-226 accumulates in specific areas of the body, such as tumors or organs. The radiation emitted by the isotope then destroys cancer cells or provides diagnostic information. MIRD-226
= Time-integrated activity (total number of nuclear disintegrations) in the source organ ( MIRD-226: The Intersection of Internal Dosimetry and Radium
) : Tissues or organs absorbing the emitted radiation from those source regions. MIRD-226